New Analysis Shows Contract Pharmacies Financially Gain From 340B Program With No Clear Benefit to Patients
October 09, 2020
October 09, 2020
WASHINGTON, Oct. 9 (TNSRep) -- The Pharmaceutical Research and Manufacturers of America issued the following news release on Oct. 8:
Today, the Berkeley Research Group (BRG) published an analysis of historical trends in 340B contract pharmacy arrangements. The findings conclude that the growth in the number of these arrangements is fueling explosive growth in the program at large and driving the 340B program farther and farther away from its original intended goal of providing disco . . .
Today, the Berkeley Research Group (BRG) published an analysis of historical trends in 340B contract pharmacy arrangements. The findings conclude that the growth in the number of these arrangements is fueling explosive growth in the program at large and driving the 340B program farther and farther away from its original intended goal of providing disco . . .